Aurobindo Pharma Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 61,768.4 million compared to INR 56,918.5 million a year ago. Revenue was INR 62,765.4 million compared to INR 58,118.8 million a year ago. Net income was INR 5,205.4 million compared to INR 7,699.7 million a year ago. Basic earnings per share from continuing operations was INR 8.88 compared to INR 13.14 a year ago. Diluted earnings per share from continuing operations was INR 8.88 compared to INR 13.14 a year ago.